Head and Neck Paragangliomas: Patterns of Otolaryngology Referrals for Genetic Testing Over 2 Decades
- PMID: 33748650
- PMCID: PMC7940728
- DOI: 10.1177/2473974X21995453
Head and Neck Paragangliomas: Patterns of Otolaryngology Referrals for Genetic Testing Over 2 Decades
Abstract
Objective: A large proportion of head and neck paragangliomas (HNPGLs) arise in patients with a genetic predisposition due to pathogenic variants in succinate dehydrogenase (SDHx) genes. Contemporary practice guidelines recommend consideration of referral for genetic testing for all patients with HNPGLs. We sought to assess adherence to these recommendations, factors associated with referral, and temporal trends in referral patterns by otolaryngologists over the past 2 decades.
Study design: Retrospective cohort study.
Setting: Single tertiary care center.
Methods: All patients with newly diagnosed HNPGLs treated at a single academic center between 2000 and 2019 were included. Bivariable association of specific features of referral for genetic testing by treating surgeons were tested with χ2 and Wilcoxon rank-sum tests. Logistic regression was used to assess temporal trends in referral patterns overall and for specific clinical subgroups over time.
Results: Of 221 patients included, only 77 (34.8%) were referred for genetic testing. Factors associated with referral included young age, family history of paraganglioma, more recent year of diagnosis (ie, closer to study end date), tumor subsite (all P < .0001), and treatment by an otolaryngologist (vs vascular surgeon or neurosurgeon, P = .009). Overall, referral rates increased over time (P = .0002), but even in the most recent 5 years, only 51% of newly diagnosed patients were referred.
Conclusion: Our analysis suggests that referral rates for genetic testing in patients with HNPGLs are growing yet are still largely based on young age, family history, and tumor subsite.
Keywords: genetic testing; head and neck; paraganglioma; succinate dehydrogenase.
© The Authors 2021.
Figures
Similar articles
-
Management and follow-up strategies for patients with head and neck paraganglioma.Eur J Endocrinol. 2024 Sep 30;191(4):389-398. doi: 10.1093/ejendo/lvae113. Eur J Endocrinol. 2024. PMID: 39303070
-
Characterization of Malignant Head and Neck Paragangliomas at a Single Institution Across Multiple Decades.JAMA Otolaryngol Head Neck Surg. 2019 Jul 1;145(7):641-646. doi: 10.1001/jamaoto.2019.1110. JAMA Otolaryngol Head Neck Surg. 2019. PMID: 31194233 Free PMC article.
-
Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas.Head Neck. 2019 Jan;41(1):79-91. doi: 10.1002/hed.25386. Epub 2018 Dec 14. Head Neck. 2019. PMID: 30549360
-
Contemporary management of paragangliomas of the head and neck.Laryngoscope Investig Otolaryngol. 2021 Nov 26;7(1):93-107. doi: 10.1002/lio2.706. eCollection 2022 Feb. Laryngoscope Investig Otolaryngol. 2021. PMID: 35155787 Free PMC article. Review.
-
Familial paraganglioma syndrome: applying genetic screening in otolaryngology.J Otolaryngol Head Neck Surg. 2010 Dec;39(6):646-53. J Otolaryngol Head Neck Surg. 2010. PMID: 21144359 Review.
References
-
- Else T, Fishbein L. Discovery of new susceptibility genes: proceed cautiously. Genet Med. 2018;20(12):1512-1514. - PubMed
-
- Baysal BE, Ferrell RE, Willett-Brozick JE, et al.. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science. 2000;287:848-851. - PubMed
-
- Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet. 2000;26:268-270. - PubMed
-
- Else T. Pheochromocytoma, paraganglioma and genetic syndromes: a historical perspective. Endocr Relat Cancer. 2015;22:T147-T159. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous